切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2015, Vol. 04 ›› Issue (06) : 648 -652. doi: 10.3877/cma.j.issn.2095-3224.2015.06.16

所属专题: 文献

综述

急性结肠假性梗阻的诊治进展
奚春华1, 沙杜1, 孙跃明1,()   
  1. 1. 210029 南京医科大学第一附属医院普通外科
  • 收稿日期:2015-10-17 出版日期:2015-12-25
  • 通信作者: 孙跃明
  • 基金资助:
    江苏省科技厅基础研究计划(BK20131448)

The progress of diagnosis and treatment of acute colonic pseudo obstruction

Chunhua Xi1, Sha Du1, Yueming Sun1,()   

  1. 1. Department of general surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
  • Received:2015-10-17 Published:2015-12-25
  • Corresponding author: Yueming Sun
  • About author:
    Corresponding author: Sun Yueming, Email:
引用本文:

奚春华, 沙杜, 孙跃明. 急性结肠假性梗阻的诊治进展[J]. 中华结直肠疾病电子杂志, 2015, 04(06): 648-652.

Chunhua Xi, Sha Du, Yueming Sun. The progress of diagnosis and treatment of acute colonic pseudo obstruction[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2015, 04(06): 648-652.

急性结肠假性梗阻(acute colonic pseudo-obstruction,ACPO)逐步为临床所认知,但很多方面还有待深入研究,其诊治依然是临床医生需要面临的挑战。随着对ACPO病因病理的深入了解,其流行病学也在发生着改变。结肠梗阻患者应警惕ACPO,一般情况下,多可通过影像学检查排除机械性梗阻。早期诊断是关键,保守治疗多可治愈。保守治疗无效者可尝试新斯的明药物治疗,但目前用药浓度、给药方式尚存争议。对于新斯的明治疗无效及复发的问题亟需研发新的药物。药物治疗禁忌或疗效欠佳者可行内镜治疗,放置减压管或经皮内镜下盲肠造瘘术等新技术有着良好的临床疗效。手术干预作为治疗最终手段,往往伴随着较高的死亡率和并发症。因此,临床医师应全面了解所有治疗手段,综合使用保守、药物和内镜治疗,造福患者。

The clinical knowledge of ACPO (acute colorectal pseudo-obstruction) is progressively improving but there is a lot of further studies to be done; the diagnosis and treatment are still a challenge for clinical practitioners. With respect to the deep understanding of ACPO, etiology and epidemiology are also undergoing changes. ACPO should be alerted in patients with intestinal obstruction and mechanical obstruction should be ruled out through imaging studies. Early diagnosis is the key, conservative treatment can be tried as the next step in management but the concentration of drug needs to be ensured. There is need for research to be done about new drugs for ACPO and prevent its? relapse. Endoscopic treatment is feasible when met with contraindications for drug treatment or poor efficacy of drugs; new technologies of endoscopy such as vacuum tube or endoscopic cecal gastrostomy have provided effective clinical effect. The last resort of treatment is surgical intervention but it is accompanied with high mortality and complications. Therefore, clinicians should be fully aware of all treatment methods; comprehensive use of conservative treatment and endoscopy for the welfare of the patients.

[1]
OgilvieH. Large-intestine colic due to sympathetic deprivation;a new clinical syndrome. Br Med J, 1948, 2(4579): 671-673.
[2]
Dudley HA, Sinclair IS, Mclaren IF, et al.Intestinal pseudo-obstruction. J R Coll Surg Edinb, 1958, 3(3): 206-217.
[3]
Dudley HA, Paterson-Brown S, Pseudo-obstruction. Br Med J (Clin Res Ed), 1986, 292(6529): 1157-1158.
[4]
Nanni G, Garbini A, Luchetti P, et al. Ogilvieʹs syndrome (acute colonic pseudo-obstruction): review of theliterature (October 1948 to March 1980) and report of four additional cases. Dis ColonRectum, 1982, 25(2): 157-166.
[5]
Rex DK. Colonoscopy and acute colonic pseudo-obstruction. Gastrointest Endosc Clin NAm, 1997, 7(3): 499-508.
[6]
Durai R. Colonic pseudo-obstruction. Singapore Med J, 2009, 50(3): 237-244.
[7]
Vanderwinden JM.Role of Interstitial Cells of Cajal and their relationship with the enteric nervous system. Eur J Morphol, 1999, 37(4-5): 250-256.
[8]
Jain D, Moussa K, Tandon M, et al. Role of interstitial cells of Cajal in motility disorders of the bowel. Am J Gastroenterol, 2003, 98(3): 618-624.
[9]
Mourelle M, Vilaseca J, Guarner F, et al. Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am J Physiol, 1996, 270(3 Pt 1): G425-430.
[10]
Akiho H, Ihara E, Motomura Y, et al.Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.World J Gastrointest Pathophysiol, 2011, 2(5): 72-81.
[11]
Vanek VW, Al-Salti M.Acute pseudo-obstruction of the colon (Ogilvieʹs syndrome). Ananalysis of 400 cases. Dis Colon Rectum, 1986, 29(3): 203-210.
[12]
Kaiser AM.Ogilvie transition to colonic perforation. Am J Surg, 2010, 200(1): e15-16.
[13]
Davis L, Lowman RM. An evaluation of cecal size in impending perforation of the cecum. Surg Gynecol Obstet, 1956, 103(6): 711-718.
[14]
Saunders MD, Kimmey MB. Systematic review: acute colonic pseudo-obstruction. Aliment Pharmacol Ther, 2005, 22(10): 917-925.
[15]
Godfrey EM, Addley HC, Shaw AS. The use of computed tomography in the detection and characterisation of large bowel obstruction. N Z Med J, 2009, 122(1305): 57-73.
[16]
Wegener M, Börsch G. Acute colonic pseudo-obstruction (Ogilvieʹs syndrome). Presentation of 14 of our own cases and analysis of 1027 cases reported in the literature.Surg Endosc, 1987, 1(3): 169-174.
[17]
Beattie GC, Peters RT, Guy S, et al. Computed tomography in the assessment of suspected large bowel obstruction. ANZ J Surg, 2007, 77(3): 160-165.
[18]
De Giorgio R, Knowles CH. Acute colonic pseudo-obstruction. Br J Surg, 2009, 96(3): 229-239.
[19]
ASGE Standards of Practice Committee, Banerjee S, Cash BD, et al. The role of endoscopy in the management of patients with peptic ulcer disease. Gastrointest Endosc, 2010, 71(4): 663-668.
[20]
Bonacini M, Smith OJ, Pritchard T. Erythromycin as therapy for acute colonic pseudoobstruction (Ogilvie’s syndrome). J Clin Gastroenterol, 1991, 13(4): 475-476.
[21]
Lipton AB, Knauer CM.Pseudo-obstruction of the bowel. Therapeutic trial of metoclopramide. Am J Dig Dis, 1977, 22(3): 263-265.
[22]
Emmanuel AV, Shand AG, Kamm MA. Kamm. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther, 2004, 19(6): 687-694.
[23]
Hutchinson R, Griffiths C.Acute colonic pseudo-obstruction: a pharmacological approach. Ann R Coll Surg Engl, 1992, 74(5): 364-367.
[24]
Coskun H, Mihmanli M. Neostigmine for the treatment of acute colonic pseudo-obstruction (Ogilvieʹs syndrome) in a patient on CAPD. Perit Dial Int, 2004, 24(1): 85-87.
[25]
Stephenson BM, Morgan AR, Salaman JR, et al.Ogilvieʹs syndrome: a new approach to an old problem. Dis Colon Rectum, 1995, 38(4): 424-427.
[26]
Amaro R, Rogers AINeostigmine infusion: new standard of care for acute colonic pseudo-obstruction? .Am J Gastroenterol, 2000, 95(1): 304-305.
[27]
Trevisani GT, Hyman NH, Church JM.Neostigmine: safe and effective treatment for acute colonic pseudo-obstruction. Dis Colon Rectum, 2000, 43(5): 599-603.
[28]
van der Spoel JI, Oudemans-van Straaten HM, Stoutenbeek CP, et al.Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure--a prospective, double-blind, placebocontrolled trial. Intensive Care Med, 2001, 27(5): 822-827.
[29]
Mehta R, John A, Nair P, et al.Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo-obstruction: a prospective study. J Gastroenterol Hepatol, 2006, 21(2): 459-461.
[30]
Paran H, Silverberg D, Mayo A, et al.Treatment of acute colonic pseudo-obstruction with neostigmine. J Am Coll Surg, 2000, 190(3): 315-318.
[31]
White L, G. Sandhu.Continuous neostig mine infusion versus bolus neostigmine in refractory Ogilvie syndrome. Am J Emerg Med, 2011, 29(5): 576 e1-3.
[32]
Sgouros SN, Vlachogiannakos J, Vassiliadis K, et al.Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. Gut, 2006, 55(5): 638-642.
[33]
OʹDea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis, 2010, 12(6): 540-548.
[34]
Maggi L, Mantegazza R.Treatment of myasthenia gravis: focus on pyridostigmine. Clin Drug Investig, 2011, 31(10): 691-701.
[35]
Thomas J, Karver S, Cooney GA, et al.Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med, 2008, 358(22): 2332-2343.
[36]
Weinstock LB, Chang AC.Methylnaltrexone for treatment of acute colonic pseudoobstruction. J Clin Gastroenterol, 2011, 45(10): 883-884.
[37]
Holzer P.Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effects. Curr Opin Anaesthesiol, 2010, 23(5): 616-622.
[38]
Gonenne J, Camilleri M, Ferber I, et al. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol, 2005, 3(8): 784-791.
[39]
Kukora JS, Dent TL.Colonoscopic decompression of massive nonobstructive cecal dilation. Arch Surg, 1977, 112(4): 512-517.
[40]
Geller A, Petersen BT, Gostout CJ. Endoscopic decompression for acute colonic pseudo-obstruction. Gastrointest Endosc, 1996, 44(2): 144-150.
[41]
Kahi CJ, Rex DK.Bowel obstruction and pseudo-obstruction. Gastroenterol Clin North Am, 2003, 32(4): 1229-1247.
[42]
Lynch CR, Jones RG, Hilden K, et al. Percutaneous endoscopic cecostomy in adults: a case series. Gastrointest Endosc, 2006, 64(2): 279-282.
[43]
Baraza W, Brown S, McAlindon M, et al.Prospective analysis of percutaneous endoscopic colostomy at a tertiary referral centre. Br J Surg, 2007, 94(11): 1415-1420.
[44]
Bertolini D, De Saussure P, Chilcott M, et al.Severe delayed complication after percutaneous endoscopic colostomy for chronic intestinal pseudo-obstruction: a case report and review of the literature. World J Gastroenterol, 2007, 13(15): 2255-2257.
[45]
vanSonnenberg E, Varney RR, Casola G, et al.Percutaneous cecostomy for Ogilvie syndrome: laboratory observations and clinical experience. Radiology, 1990, 175(3): 679-682.
[46]
Crass JR, Simmons RL, Frick MP, et al.Percutaneous decompression of the colon using CT guidance in Ogilvie syndrome. AJR Am J Roentgenol, 1985, 144(3): 475-476.
[47]
Maloney N, Vargas HD. Vargas, Acute intestinal pseudo-obstruction (Ogilvie’s syndrome). Clin Colon Rectal Surg, 2005, 18(2): 96-101.
[48]
Duh QY, Way LW.Diagnostic laparoscopy and laparoscopic cecostomy for colonic pseudo-obstruction. Dis Colon Rectum, 1993, 36(1): 65-70.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 蒋佳纯, 王晓冰, 陈培荣, 许世豪. 血清学指标联合常规超声及超声造影评分诊断原发性干燥综合征的临床价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 622-630.
[3] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[4] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[5] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[6] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[7] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[8] 袁成雪, 张宗霞, 许婷, 斯郎拉姆. 三种内镜手术治疗结肠息肉的效果及安全性观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 78-81.
[9] 燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[10] 程相阵. 腹茧症9例诊治分析并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(9): 968-971.
[11] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[12] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[13] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
阅读次数
全文


摘要